Imaging compound for Alzheimer's
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
16
NCT05453539
Proof-of-concept Study of New Imaging Diagnostic in Patients With Suspected Alzheimer's Disease
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 9, 2022
Completion: Nov 8, 2024
Loading map...